Northern Trust’s GeoVax Labs GOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-108
Closed -$11.1K – 4461
2025
Q4
$11.1K Buy
108
+89
+468% +$23.5K ﹤0.01% 4430
2025
Q3
$5.52K Hold
19
– – ﹤0.01% 4417
2025
Q2
$10.1K Hold
19
– – ﹤0.01% 4373
2025
Q1
$12.4K Hold
19
– – ﹤0.01% 4376
2024
Q4
$28.8K Buy
+19
New +$26.4K ﹤0.01% 4340
2024
Q1
– Sell
-4
Closed -$12.4K – 4446
2023
Q4
$12.4K Hold
4
– – ﹤0.01% 4407
2023
Q3
$17.6K Hold
4
– – ﹤0.01% 4351
2023
Q2
$18.8K Hold
4
– – ﹤0.01% 4418
2023
Q1
$22.8K Buy
4
+1
+33% +$6.74K ﹤0.01% 4426
2022
Q4
$16.1K Hold
3
– – ﹤0.01% 4524
2022
Q3
$28K Buy
3
+2
+200% +$27.7K ﹤0.01% 4477
2022
Q2
$10K Hold
1
– – ﹤0.01% 4692
2022
Q1
$13K Hold
1
– – ﹤0.01% 4687
2021
Q4
$42K Hold
1
– – ﹤0.01% 4617
2021
Q3
$50K Hold
1
– – ﹤0.01% 4534
2021
Q2
$58K Buy
+1
New +$46.7K ﹤0.01% 4467

Other funds holding GOVX

Northern Trust's GOVX Position: Q1 2026 in Review

Northern Trust sold out of GeoVax Labs (GOVX) in Q1 2026, closing a stake of 108 shares — an estimated $11.1K sold.

Northern Trust first reported a position in GOVX in Q2 2021 and held it in 16 quarters. The position peaked at $58K in Q2 2021. 10 funds tracked by Wall St. Rank hold GOVX as of Q1 2026.

  • Northern Trust reported no remaining GeoVax Labs position as of Q1 2026 after selling out during the quarter.
  • Northern Trust sold 108 GeoVax Labs shares in Q1 2026, an estimated $11.1K.
  • Northern Trust first reported a position in GeoVax Labs in Q2 2021 and held it in 16 quarters.
  • Northern Trust's GeoVax Labs position peaked at $58K in Q2 2021.
  • 10 funds tracked by Wall St. Rank held GeoVax Labs as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.